Current Environment: Production

Erin Syverson | Education

Undergraduate School

University of Rochester

2008, Rochester, NY

Medical School

Jefferson Medical College

2012, Philadelphia, PA

Internship

Children's National Medical Center

2013, Washington, DC

Residency

Children's National Medical Center

2015, Washington, DC

Fellowship

Boston Children's Hospital

2019, Boston, MA

Erin Syverson | Certifications

  • American Board of Pediatrics (General)

Erin Syverson | Publications

  1. The role of dupilumab in the treatment of eosinophilic esophagitis. Immunotherapy. 2024; 16(13):845-852. View The role of dupilumab in the treatment of eosinophilic esophagitis. Abstract

  2. Piloting a multidisciplinary group education session to support caregivers of children with food protein-induced enterocolitis syndrome (FPIES). J Allergy Clin Immunol Pract. 2023 Oct; 11(10):3260-3262.e1. View Piloting a multidisciplinary group education session to support caregivers of children with food protein-induced enterocolitis syndrome (FPIES). Abstract

  3. Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2023 08 01; 77(2):256-259. View Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis. Abstract

  4. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis. Gastroenterol Hepatol (N Y). 2022 Apr; 18(4):207-212. View Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis. Abstract

  5. Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center. JPGN Rep. 2022 May; 3(2):e180. View Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center. Abstract

  6. Robust differentiation of human enteroendocrine cells from intestinal stem cells. Nat Commun. 2022 01 11; 13(1):261. View Robust differentiation of human enteroendocrine cells from intestinal stem cells. Abstract

  7. Treatment for eosinophilic esophagitis. Curr Opin Gastroenterol. 2020 11; 36(6):485-490. View Treatment for eosinophilic esophagitis. Abstract

  8. Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2020 Mar; 8(3):1107-1109. View Oral viscous mometasone is an effective treatment for eosinophilic esophagitis. Abstract

  9. Adolescents' Perceptions of Transition Importance, Readiness, and Likelihood of Future Success: The Role of Anticipatory Guidance. Clin Pediatr (Phila). 2016 Oct; 55(11):1020-5. View Adolescents' Perceptions of Transition Importance, Readiness, and Likelihood of Future Success: The Role of Anticipatory Guidance. Abstract

BESbswy
BESbswy